Skip to main content
TipRanks
Go Ultimate75% OFF

Vitura SA (VTR) AI Stock Analysis

2 Followers
FR:VTR

Vitura SA

(Paris:VTR)

Select Model
Rating:37Underperform
Price Target:EUR 2.50â–²(0.00% Upside)
Action:reiterated
Date:11/18/26

The company is in a state of financial crisis, with deep losses, a debt-laden balance sheet, and insufficient cash generation, which is the primary driver of the minimum score. This is compounded by a bearish technical trend and a negative P/E ratio with no dividend, offering no support from valuation or price momentum.

Positive Factors
Revenue reboundThe 2025 revenue rebound indicates renewed operating activity after the prior-year weakness. If maintained, stronger revenue can improve fixed-cost absorption and support operating performance, although durability depends on converting top-line recovery into consistent profits.
Negative Factors
Persistent net lossesRepeated net losses weaken retained capital and reduce confidence in the sustainability of earnings. Although EBIT turned positive in 2025, continued negative net income shows that operating improvement has not yet translated into durable bottom-line profitability or reliable returns.

Vitura SA (VTR) vs. iShares MSCI France ETF (EWQ)

-40%-20%0%20%40%60%FR:VTR-30.94%EWQ+1.77%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 42.65M
Dividend Yield
―
Average Volume (3M)
199
Price to Earnings (P/E)
-1.2
Beta (1Y)
0.66
Revenue Growth
8.96%
EPS Growth
41.13%
Country
France
Employees
2
Sector
Services
Sector Strength
55
Industry
REIT - Office

Vitura SA Business Overview & Revenue Model

Company Description

Established in 2006, Vitura operates as a publicly traded real estate investment trust (REIT), specifically designated as a "SIIC." The company's core strategy involves acquiring and managing premium office assets located within Paris and its broader...

How the Company Makes Money

Vitura makes money primarily through the sale and distribution of medicinal cannabis products and related services within the Australian regulated prescription market. Revenue is generated by supplying cannabinoid medicines (and associated product li...

Vitura SA Financial Statement Overview

Summary

Severe financial distress. Revenue has declined significantly, the company is deeply unprofitable with massive net losses, and the balance sheet is highly leveraged with eroding equity. Cash flow is insufficient to service debt, posing solvency risks.

Income Statement

25Negative

Balance Sheet

15Very Negative

Cash Flow

30Negative
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue65.53M60.32M57.87M76.61M72.78M84.92M
Gross Profit34.80M37.76M32.91M50.43M44.14M63.67M
EBITDA5.71M21.86M26.85M-166.93M41.01M45.52M
Net Income-35.75M-20.75M-243.00M-239.85M-4.18M36.93M
Balance Sheet
Total Assets901.48M920.92M940.47M1.40B1.62B1.66B
Cash, Cash Equivalents and Short-Term Investments26.61M21.64M13.49M11.72M15.17M57.48M
Total Debt641.48M644.69M644.20M855.10M835.39M833.49M
Total Liabilities679.29M672.77M671.57M883.93M868.77M890.52M
Stockholders Equity222.19M248.15M268.91M511.91M755.44M772.94M
Cash Flow
Free Cash Flow5.07M3.99M3.83M-17.45M-22.70M-69.37M
Operating Cash Flow11.21M11.38M12.61M12.04M-9.36M40.90M
Investing Cash Flow-6.25M-7.51M-2.69M-29.32M-19.47M-103.31M
Financing Cash Flow-3.09M-1.06M-8.15M13.83M-13.48M57.05M

Vitura SA Technical Analysis

Technical Analysis SentimentNegative
Last Price2.50

Price Trends

50DMA3.43Negative
100DMA3.90Negative
200DMA3.95Negative

Market Momentum

MACD-0.19Negative
RSI35.38Neutral
STOCH21.43Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:VTR, the sentiment is Negative. The current price of 2.50 is below the 20-day moving average (MA) of 2.73, below the 50-day MA of 3.43, and below the 200-day MA of 3.95, indicating a bearish trend. The MACD of -0.19 indicates Negative momentum. The RSI at 35.38 is Neutral, neither overbought nor oversold. The STOCH value of 21.43 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FR:VTR.

Vitura SA Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

FR:VTR against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
FR:AUBFR:AUB73OutperformEUR 630.61M15.2014.17%3.03%27.45%19.70%
FR:ATEFR:ATE66NeutralEUR 2.94B20.736.19%1.79%0.11%-6.28%
FR:COHFR:COH64NeutralEUR 38.78M12.8712.54%1.17%8.58%-18.77%
FR:ALCGMFR:ALCGM60NeutralEUR 124.66M-8.49-5.44%―-0.98%―
Sector *55Neutral$13.29B17.4210.03%0.93%7.13%-12.93%
FR:VTRFR:VTR37UnderperformEUR 42.65M-1.19-15.20%―8.96%41.13%
FR:ALCLAFR:ALCLA32UnderperformEUR 31.33M6.8410.38%―――

* Services Sector Average

Performance Comparison

-50%-25%0%25%50%FR:VTRFR:ATEFR:AUBFR:ALCLAFR:ALCGMFR:COHDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
FR:VTR and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
FR:VTRVitura SA2.50-1.02-28.98%
FR:ATEALTEN83.9521.0333.43%
FR:AUBAubay Société Anonyme49.552.094.41%
FR:ALCLAClaranova SA0.55-0.84-60.43%
FR:ALCGMCegedim SA9.09-2.91-24.25%
FR:COHCoheris6.82-6.99-50.62%

Vitura SA Corporate Events

Vitura Reports 8.6% Rise in Nine-Month Rental Income

Nov 10, 2026

Vitura is a French listed real estate investment company specializing in office properties in Paris and Greater Paris. In the first nine months of 2026, IFRS rental income rose 8.6% to €35.6 million from €32.9 million a year earlier, driven by new le...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 18, 2026